UNSPSC 51342505: Abacavir succinate

This classification denotes a reverse transcriptase inhibitor, in succinate form, with the molecular formula C14H18N6O.C4H6O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40FH6D8CHK, chemically known as butanedoic acid, compd. with (1s,4r)-4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol (1:1) but more generally known as abacavir succinate, which bears US NIH Compound Identifier 65139. The base compound, abacavir, also appears in sulfate form, and is sometimes combined with lamivudine and zidovudine.

UNSPSC 51342505 Abacavir succinate is a Commodity code for a specific antiretroviral pharmaceutical product; state and local governments procure this drug through pharmaceutical warehouse piggyback contracts and cooperative purchasing vehicles to support public health programs and emergency preparedness. The recent opportunities tagged under this code show minimal direct activity for abacavir itself—the Illinois Department of Public Health's MMCAP Infuse piggyback contract awarded to Chartwell Rx LLC (completed August 28, 2026) actually supplied Doxycycline Hyclate and Ciprofloxacin Hydrochloride rather than the abacavir indicated by the UNSPSC tag. State and local health departments and counties are the primary issuing bodies, typically purchasing pharmaceutical products through cooperative consortia such as MMCAP Infuse to achieve volume pricing and streamlined procurement processes.

Illinois and Florida represent the recent geographic activity in available records. The Illinois Department of Public Health's piggyback contract through MMCAP Infuse (Invitation for Bid, awarded at $2,999,999.11 over 12 months with two one-year renewal options) and Seminole County, Florida's IFB for naloxone and drug deactivation systems (response deadline July 26, 2023, quarterly deliveries required) illustrate the mix of state health departments and county governments using cooperative purchasing and competitive bidding to acquire pharmaceuticals and related supplies. The code shows limited recent open solicitations specifically for abacavir succinate; procurement activity under this code appears driven by broader pharmaceutical warehouse and emergency-response contracts where individual drug products are bundled or piggybacked under master agreements negotiated through state or regional consortia.